The estimated Net Worth of Marla Persky is at least 185 千$ dollars as of 14 November 2023. Ms. Persky owns over 6,370 units of Xeris Biopharma Inc stock worth over 18,218$ and over the last 6 years she sold XERS stock worth over 0$. In addition, she makes 166,360$ as Independent Director at Xeris Biopharma Inc.
Marla has made over 1 trades of the Xeris Biopharma Inc stock since 2023, according to the Form 4 filled with the SEC. Most recently she bought 6,370 units of XERS stock worth 10,065$ on 14 November 2023.
The largest trade she's ever made was buying 6,370 units of Xeris Biopharma Inc stock on 14 November 2023 worth over 10,065$. On average, Marla trades about 796 units every 0 days since 2019. As of 14 November 2023 she still owns at least 6,370 units of Xeris Biopharma Inc stock.
You can see the complete history of Ms. Persky stock trades at the bottom of the page.
Marla S. Persky J.D. serves as Independent Director of the Company. Ms. Persky has served on our board of directors since April 2018. Since 2014, Ms. Persky has served as the chief executive officer and president of WOMN, LLC, a consulting and coaching organization. From 2005 to 2013, Ms. Persky was senior vice president, general counsel and corporate secretary of Boehringer Ingelheim Corporation, a pharmaceutical company. Ms. Persky also serves on the board of advisors of Text IQ, Inc. and the board of directors of Ygeia Group, Inc. Ms. Persky has a B.S.S. degree in speech sciences from Northwestern University and a J.D. from Washington University School of Law.
As the Independent Director of Xeris Biopharma Inc, the total compensation of Marla Persky at Xeris Biopharma Inc is 166,360$. There are 9 executives at Xeris Biopharma Inc getting paid more, with Paul Edick having the highest compensation of 4,307,640$.
Marla Persky is 64, she's been the Independent Director of Xeris Biopharma Inc since 2018. There are 2 older and 17 younger executives at Xeris Biopharma Inc. The oldest executive at Xeris Biopharma Holdings Inc is Jeffrey Sherman, 65, who is the Independent Director.
Marla's mailing address filed with the SEC is C/O XERIS BIOPHARMA HOLDINGS, INC., 1375 WEST FULTON STREET, SUITE 1300, CHICAGO, IL, 60607.
Over the last 6 years, insiders at Xeris Biopharma Inc have traded over 2,845,230$ worth of Xeris Biopharma Inc stock and bought 2,912,235 units worth 31,442,123$ . The most active insiders traders include Group, Llc Green Jeremy Red...、James E Deerfield Mgmt L.P....、Garheng Kong. On average, Xeris Biopharma Inc executives and independent directors trade stock every 46 days with the average trade being worth of 197,048$. The most recent stock trade was executed by John P. Schmid on 12 August 2024, trading 4,515 units of XERS stock currently worth 10,159$.
xeris aspires to break through this restraint by developing ultra-low volume, ready-to-use biotherapeutics delivered through patient-friendly injectable devices. products built on our xeriject technologies could potentially ease the pain of injections for hundreds of millions of patients.
Xeris Biopharma Inc executives and other stock owners filed with the SEC include: